Clinical studies recruiting near Chisinau

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
Phase 1 · IMSP Institute of Oncology, ARENSIA Exploratory Medicine · Exscientia AI Ltd., a wholly owned subsidiary of Recursion P · NCT06980116 Study of SGR-1505 in Mature B-Cell Neoplasms
Phase 1 · Institute of Oncology, ARENSIA Exploratory Medicine · Schrödinger, Inc. · NCT05544019 PRIDE III Prison Interventions and HIV Prevention Collaboration
NA · NGO AFI · Yale University · NCT06962033 DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carbop
Phase 3 · ARENSIA Exploratory Medicine · Boehringer Ingelheim · NCT07472517 A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
Phase 1/Phase 2 · Institute of Oncology/ARENSIA Exploratory Medicine · Corbus Pharmaceuticals Inc. · NCT06265727 Validation of Sudden Cardiac Arrest Risk Factors in Patients With CAD
Phase N/A · Instituția Medico-Sanitară Publică "Institutul de Cardiologi · Tampere Heart Hospital · NCT07444931 AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
Phase 2 · Research Site · AstraZeneca · NCT06219941 A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B
Phase 1 · Arensia Exploratory Medicine Chisinau · IntegerBio · NCT07389044 A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Phase 3 · Institutul de Neurologie si Neurochirurgie · argenx · NCT07091630 An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Activ
Phase 3 · Investigational Site Number : 4980002 · Sanofi · NCT07184931 Randomized Controlled Trial of a Family-focused Intervention for Caregivers and Young Adolescents (Phase 3 of FLOURISH)
NA · Health For Youth Association · University of Klagenfurt · NCT07240571 A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Phase 2 · Site MD37301 · Astellas Pharma Global Development, Inc. · NCT02960022 A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
Phase 1/Phase 2 · The Institute of Oncology, Arensia Exploratory Medicine · BeOne Medicines · NCT05006716 A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
Phase 1/Phase 2 · The Institute of Oncology, ARENSIA Exploratory Medicine Phas · Hummingbird Bioscience · NCT05910827 A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythema
Phase 1 · Timofei Moșneaga Republican Clinical Hospital · Cullinan Therapeutics Inc. · NCT06613360 A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
Phase 1 · PMSI Republican Clinical Hospital "T.Mosneaga" ( Site 1001) · Merck Sharp & Dohme LLC · NCT07363590 Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B
Phase 1 · PMSI Republican Clinical Hospital "Timofei Mosneaga", Arensi · Tune Therapeutics, Inc. · NCT06671093 A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to
Phase 3 · Research site 116001 · mAbxience Research S.L. · NCT06687369 BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
Phase 1 · The Institute of Oncology, Arensia Exploratory Medicine · BeOne Medicines · NCT06120283 A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis
Phase 1 · Jade Clinical Site · Jade Biosciences, Inc. · NCT07533955 Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B
Phase 1 · ICS ARENSIA Exploratory Medicine SRL · Precision BioSciences, Inc. · NCT06680232 REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Particip
Phase 3 · PMSI Emergency Medicine Institute · Regeneron Pharmaceuticals · NCT07213778 A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLI
Phase 1/Phase 2 · National Institute of Oncology, Arensia Research Clinic · Jiangsu HengRui Medicine Co., Ltd. · NCT05277168 Study of GS-0151 in Participants With Rheumatoid Arthritis
Phase 1 · Republican Clinical Hospital "Timofei Mosneaga," Arensia EM · Gilead Sciences · NCT06902519 Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis
Phase 1 · Clinical Republican Hospital "Timofei Mosneaga", ARENSIA E.M · Lifordi Immunotherapeutics, Inc. · NCT07207954 An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With A
Phase 1 · The Institute of Oncology, Arensia Exploratory Medicine · BeOne Medicines · NCT06589596 A Phase 1b Open-label Study to Evaluate Safety of Plamotamab in Participants With Rheumatoid Arthritis
Phase 1 · Xencor Investigative Site · Xencor, Inc. · NCT07230353 A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
Phase 2 · Investigational Site Number: 4980001 · Sanofi · NCT06975722 Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis
Phase 2 · IMSP Sptalul Clinic Municipal "Sfanta Treime" · KeyBioscience AG · NCT06833749 A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Phase 2 · Site 713 · Spyre Therapeutics, Inc. · NCT07012395

Look up another city

Look up another condition